Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.58 |
| ▸ | BAD | Q92934 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | THRA | P10827 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | RXRA | P19793 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30717272 | 1.00 | BCL2L1 (0.58) | BCL2L1BADTSHRALDH1A1ALOX12 | |
| SCHEMBL5598514 | 0.98 | BCL2L1 (0.56) | BCL2L1BADTSHRALDH1A1ALOX12 | |
| SCHEMBL31011900 | 0.98 | BCL2L1 (0.56) | BCL2L1BADTSHRALDH1A1ALOX12 | |
| SCHEMBL413550 | 0.95 | BCL2L1 (0.52) | BCL2L1BADTSHRALDH1A1ALOX12 | |
| SCHEMBL29892288 | 0.95 | BCL2L1 (0.52) | BCL2L1BADTSHRALDH1A1ALOX12 | |
| Dimethylamine SCHEMBL6542165 | 0.91 | BCL2L1 (0.50) | BCL2L1BADTSHRALDH1A1ALOX12 | |
| SCHEMBL11352084 | 0.87 | — | — | |
| SCHEMBL6542200 | 0.83 | ALDH1A1 (0.47) | BCL2L1BADTSHRALDH1A1MEN1 | |
| SCHEMBL19684557 | 0.80 | PNMT (0.47) | BCL2L1BADMEN1KMT2A | |
| SCHEMBL7056082 | 0.80 | BCL2L1 (0.41) | BCL2L1BADTSHRALDH1A1ALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111341920-B | Organic electroluminescent device | 固安鼎材科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-112018248-B | Display device and preparation method thereof | 固安鼎材科技有限公司 | 2023-12-29 | — | — | CN | claimed |
| US-11637257-B2 | Electroluminescent material ink and electroluminescent device thereof | GUANGDONG JUHUA PRINTED DISPLAY TECHNOLOGY CO. LTD (CN) | 2023-04-25 | — | — | US | claimed |
| CN-109929328-B | Composite ink and preparation method and device thereof | TCL科技集团股份有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-112018248-A | Display device and preparation method thereof | 固安鼎材科技有限公司 | 2020-12-01 | — | — | CN | claimed |
| US-20200373508-A1 | ELECTROLUMINESCENT MATERIAL INK AND ELECTROLUMINESCENT DEVICE THEREOF | GUANGDONG JUHUA PRINTED DISPLAY TECHNOLOGY CO., LTD. (CN) | 2020-11-26 | — | — | US | claimed |
| CN-108948865-B | Electroluminescent material ink and electroluminescent device thereof | 广东聚华印刷显示技术有限公司 | 2020-07-10 | — | — | CN | claimed |
| CN-111341920-A | Organic electroluminescent device | 固安鼎材科技有限公司 | 2020-06-26 | — | — | CN | claimed |
| CN-111211235-A | Organic electroluminescent device | 固安鼎材科技有限公司 | 2020-05-29 | — | — | CN | claimed |
| CN-110386894-A | A kind of hole mobile material and its application | 北京鼎材科技有限公司 | 2019-10-29 | — | — | CN | claimed |
| CN-109929328-A | A kind of compound ink and preparation method thereof, device | TCL集团股份有限公司 | 2019-06-25 | — | — | CN | claimed |
| CN-108948865-A | Electroluminescent material ink and its electroluminescent device | 广东聚华印刷显示技术有限公司 | 2018-12-07 | — | — | CN | claimed |
| US-6797700-B2 | ANTICOAGULANTS | AVENTIS PHARMACEUTICALS, INC. | 2004-09-28 | — | — | US | claimed |
| US-6274705-B1 | INHIBIT PLATELET AGGREGATION AND THROMBUS FORMATION, USEFUL IN PREVENTION AND TREATMENT OF THROMBOSIS | AVENTIS PHARMACEUTICALS PRODUCTS INC. | 2001-08-14 | — | — | US | claimed |
| US-5866685-A | Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1999-02-02 | — | — | US | claimed |
| US-5073654-A | Catalyzing in presence of zeolite type beta | UOP (US) | 1991-12-17 | — | — | US | claimed |
| CN-110386894-B | Hole transport material and application thereof | Beijing Dingcai Technology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-4511460-A | Minimizing corrosion in coal liquid distillation | INTERNATIONAL COAL REFINING COMPANY (US) | 1985-04-16 | — | — | US | disclosed |
| US-3973033-A | Compositions and methods for producing a vasodilatory effect with a naphthyl tetrahydrofurfuryl amino-ester | LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | BCL2L1 2233/4885BAD 4518/4885TSHR 830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.